DeepCurrents Investment Group »

Eliem Therapeutics shares owned by DeepCurrents Investment Group

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by DeepCurrents Investment Group from 13F filings

Historical chart of DeepCurrents Investment Group investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by DeepCurrents Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by DeepCurrents Investment Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $838k 64k 13.04

More positions owned by DeepCurrents Investment Group

Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Bitcoin Trust Etf Shs Ben Int Put Option (IBIT)
Interdigital Note 3.500% 6/0 (Principal)
Select Sector Spdr Tr St Str Energ Etf Put Option (XLE)
Applied Digital Corp Note 2.750% 6/0 (Principal)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Repligen Corp Note 1.000%12/1 (Principal)
MKS Note 1.250% 6/0 (Principal)
Snowflake Note 10/0 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Cloudflare Note 8/1 (Principal)
Draftkings Note 3/1 (Principal)
Alignment Healthcare Note 4.250%11/1 (Principal)
Teladoc Health Note 1.250% 6/0 (Principal)
Xometry Note 0.750% 6/1 (Principal)

View all positions for DeepCurrents Investment Group

Top funds holding Eliem Therapeutics

RA Capital Management
FMR
UBS Group
Braidwell
Adage Capital Partners GP
BlackRock
Cormorant Asset Management
Frontier Capital Management
T. Rowe Price Associates
Vanguard Capital Management
Woodline Partners
Citadel Advisors
Redmile Group
Dr. Jeffrey R. Jay, M.D.
Affinity Asset Advisors

View all funds holding Eliem Therapeutics